Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a Novel Subtype of Ocular Hypertensive Eyes with the Lowest Risk of Progression Under Treatment.

Ophthalmology and therapy·2025
Same author

Visual Field Progression in the Ocular Hypertension Treatment Study.

American journal of ophthalmology·2024
Same author

Comparison of a Novel Head-mounted Perimeter vs. the Humphrey Field Analyzer.

Ophthalmology. Glaucoma·2024
Same author

Identifying Factors Associated With Fast Visual Field Progression in Patients With Ocular Hypertension Based on Unsupervised Machine Learning.

Journal of glaucoma·2024
Same author

An Artificial Intelligence Enabled System for Retinal Nerve Fiber Layer Thickness Damage Severity Staging.

Ophthalmology science·2023
Same author

A deep learning model incorporating spatial and temporal information successfully detects visual field worsening using a consensus based approach.

Scientific reports·2023

Related Experiment Video

Updated: Jul 16, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Staging functional damage in glaucoma: review of different classification methods.

Paolo Brusini1, Chris A Johnson

  • 1Department of Ophthalmology - Santa Maria della Misericordia Hospital, Udine, Italy.

Survey of Ophthalmology
|March 16, 2007
PubMed
Summary

Classifying glaucoma visual field defects is crucial for diagnosis, treatment, and research. This review examines 40 years of proposed methods, highlighting the need for standardized approaches to glaucoma severity assessment.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Functional Magnetic Resonance Imaging (fMRI) of the Visual Cortex with Wide-View Retinotopic Stimulation
07:11

Functional Magnetic Resonance Imaging (fMRI) of the Visual Cortex with Wide-View Retinotopic Stimulation

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Jul 16, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Functional Magnetic Resonance Imaging (fMRI) of the Visual Cortex with Wide-View Retinotopic Stimulation
07:11

Functional Magnetic Resonance Imaging (fMRI) of the Visual Cortex with Wide-View Retinotopic Stimulation

Published on: December 8, 2023

Area of Science:

  • Ophthalmology
  • Visual Neuroscience
  • Medical Imaging

Background:

  • Glaucoma visual field defects require accurate classification for effective patient management.
  • Current classification methods lack widespread clinical adoption.
  • Standardized criteria are needed for homogeneous grouping, therapy adjustment, and disease monitoring.

Purpose of the Study:

  • To review and analyze various methods for classifying glaucomatous visual field defects over the past 40 years.
  • To identify the strengths and limitations of existing classification approaches.
  • To inform the development of more effective and clinically applicable classification systems.

Main Methods:

  • Literature review of proposed glaucoma visual field defect classification methods.
  • Analysis of classification techniques, including the Bebie curve for visual field loss patterns (diffuse, localized, mixed).
  • Evaluation of the historical development and clinical utility of different classification systems.

Main Results:

  • Numerous classification methods for glaucomatous visual field defects have been proposed.
  • No single method has achieved widespread clinical use.
  • The cumulative defect curve (Bebie curve) offers insights into visual field loss patterns.

Conclusions:

  • Accurate classification of glaucoma severity is vital for clinical practice and research.
  • There is a persistent need for standardized, widely accepted methods for classifying visual field defects.
  • Further research is warranted to develop and validate robust classification systems for glaucoma management.